Bio-Thera Solutions Provides Regulatory and Clinical Development Updates for Proposed Biosimilars

Published date21 August 2018
Law FirmGoodwin
Subject MatterChina,Prescription Drugs,Biosimilars,China FDA,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT